Who owns Fennec Pharmaceuticals Inc?
- Ticker: FENC
- CUSIP Number: 31447p100
Tip: Access positions for across all investors
Analyze quarterly positions in Fennec Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Fennec Pharmaceuticals stock
Who bought or sold Fennec Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Southpoint Capital Advisors | 4.1M | $45M | 0% | Mar 2024 |
|
| Sonic GP | 2.4M | $27M | 0% | Mar 2024 |
|
| venBio Select Advisor | 1.2M | $14M | 0% | Dec 2023 |
|
| Solas Capital Management | 1.1M | $12M | -36% | Mar 2024 |
|
| DG Capital Management | 1.1M | $12M | -6% | Dec 2023 |
|
| Vanguard Group | 1.0M | $11M | -11% | Mar 2024 |
|
| BlackRock | 928k | $10M | 10% | Mar 2024 |
|
| AIGH Capital Management | 570k | $6.3M | 73% | Mar 2024 |
|
| Jeffrey L. Gendell | 303k | $3.4M | 7% | Mar 2024 |
|
| Geode Capital Management | 220k | $2.4M | 7% | Mar 2024 |
|
| Lion Point Capital | 170k | $1.9M | 55% | Mar 2024 |
|
| Essex Investment Management | 144k | $1.6M | 100% | Mar 2024 |
|
| Northern Trust | 114k | $1.3M | 3% | Mar 2024 |
|
| Morgan Stanley | 74k | $824k | 74% | Mar 2024 |
|
| CIBC World Markets | 70k | $779k | -12% | Mar 2024 |
|
| Citadel Advisors | 65k | $725k | 552% | Mar 2024 |
|
| Millennium Management | 59k | $651k | 307% | Mar 2024 |
|
| Legato Capital Management | 57k | $635k | 100% | Mar 2024 |
|
| Susquehanna International | 49k | $549k | 73% | Mar 2024 |
|
| Bank of New York Mellon | 48k | $535k | 5% | Mar 2024 |
|
| 683 Capital Management | 48k | $535k | -66% | Mar 2024 |
|
| Hartford Financial Management | 48k | $532k | 1% | Mar 2024 |
|
| Goldman Sachs Group | 43k | $479k | 39% | Mar 2024 |
|
| Charles Schwab Investment Management | 42k | $461k | 0% | Mar 2024 |
|
| Arrowstreet Capital, Limited Partnership | 40k | $444k | 100% | Mar 2024 |
|
| Eudaimonia Advisors | 35k | $393k | 8% | Mar 2024 |
|
| Russell Investments | 34k | $381k | 71275% | Mar 2024 |
|
| Squarepoint Ops | 34k | $375k | 100% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 33k | $364k | 68% | Mar 2024 |
|
| UBS Group | 30k | $329k | 48% | Mar 2024 |
|
| Wexford Capital | 26k | $294k | 0% | Mar 2024 |
|
| Nuveen Asset Management | 26k | $289k | 6% | Mar 2024 |
|
| Rhumbline Advisers | 20k | $224k | 1% | Mar 2024 |
|
| Bank of America Corporation | 17k | $183k | -59% | Mar 2024 |
|
| Jane Street | 16k | $173k | 100% | Mar 2024 |
|
| Jump Financial | 14k | $158k | 100% | Dec 2023 |
|
| Barclays | 13k | $143k | -49% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 12k | $137k | 9% | Mar 2024 |
|
| Worth Venture Partners | 10k | $115k | -93% | Mar 2024 |
|
| Cubist Systematic Strategies | 10k | $113k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 9.8k | $109k | -25% | Mar 2024 |
|
| New York State Common Retirement Fund | 9.8k | $108k | -8% | Mar 2024 |
|
| MetLife Investment Advisors | 9.7k | $109k | 0% | Dec 2023 |
|
| American International | 9.0k | $101k | 0% | Dec 2023 |
|
| Qube Research & Technologies | 8.9k | $99k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 6.0k | $67k | 15% | Mar 2024 |
|
| FMR | 5.1k | $56k | 1097% | Mar 2024 |
|
| Citigroup | 4.7k | $52k | 74% | Mar 2024 |
|
| State of Wyoming | 2.1k | $23k | -16% | Mar 2024 |
|
| California State Teachers Retirement System | 1.8k | $20k | -54% | Mar 2024 |
|
| Legal & General Group | 1.7k | $19k | 0% | Mar 2024 |
|
| Atlantic Trust | 1.6k | $17k | 100% | Mar 2024 |
|
| Summit Investment Advisors | 1.5k | $17k | 0% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 1.0k | $11k | 0% | Dec 2023 |
|
| Amalgamated Bank | 612.00 | $7.0k | -67% | Mar 2024 |
|
| Royal Bank of Canada | 596.00 | $0 | -92% | Mar 2024 |
|
| Tower Research Capital | 390.00 | $4.3k | -73% | Mar 2024 |
|
| Point72 | 256.00 | $2.8k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 150.00 | $1.7k | 36% | Mar 2024 |
|
| Cornerstone Planning Group | 66.00 | $609.998400 | 100% | Mar 2024 |
|
| CWM | 8.00 | $0 | 100% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 3.00 | $33.000000 | 100% | Mar 2024 |
|
Who sold out of Fennec Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bridgeway Capital Management | Sep 2023 | 34k | $257k |
| Mirae Asset Global Investments | Dec 2023 | 10k | $117k |
| Pnc Financial Services | Dec 2023 | 87.00 | $976.000800 |
| Simplex Trading | Dec 2023 | 12.00 | $0 |